The modification of natural products for medical use

被引：240
作者：
Guo, Zongru [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
来源：
ACTA PHARMACEUTICA SINICA B | 2017年 / 7卷 / 02期
关键词：
Natural products; Synthesis; Multi-dimensional optimization; Structure-acitivity reactivity; Artemisinin; Indirubin; 2; SGLT2; INHIBITOR; ANTIMALARIAL-DRUG; C-GLUCOSIDE; IN-VITRO; DISCOVERY; POTENT; ANTAGONISTS; ANALOGS; DESIGN; RING;
D O I：
10.1016/j.apsb.2016.06.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Drug innovation is characterized by painstaking molecular-level syntheses and modifications as the basic components of research and development. Similarly, natural products are chemically tailored and modified based upon their structural and biological properties. To some extent, the modification of natural products is quite different from de novo structure-based drug discovery. This review describes the general strategies and principles for the modification of natural products to drugs, as illustrated by several successful medicines that originated from natural products. (C) 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码：119 / 136
页数：18
相关论文
共 51 条
  • [1] TOTAL SYNTHESIS OF HALICHONDRIN-B AND NORHALICHONDRIN-B
    AICHER, TD
    BUSZEK, KR
    FANG, FG
    FORSYTH, CJ
    JUNG, SH
    KISHI, Y
    MATELICH, MC
    SCOLA, PM
    SPERO, DM
    YOON, SK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (08) : 3162 - 3164
  • [2] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
    ALBERTS, AW
    CHEN, J
    KURON, G
    HUNT, V
    HUFF, J
    HOFFMAN, C
    ROTHROCK, J
    LOPEZ, M
    JOSHUA, H
    HARRIS, E
    PATCHETT, A
    MONAGHAN, R
    CURRIE, S
    STAPLEY, E
    ALBERSSCHONBERG, G
    HENSENS, O
    HIRSHFIELD, J
    HOOGSTEEN, K
    LIESCH, J
    SPRINGER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
  • [3] Total synthesis of (-)-epothilone A
    Balog, A
    Meng, DF
    Kamenecka, T
    Bertinato, P
    Su, DS
    Sorensen, EJ
    Danishefsky, S
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1996, 35 (23-24): : 2801 - 2803
  • [4] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL RETINOID-X RECEPTOR-SELECTIVE RETINOIDS
    BOEHM, MF
    ZHANG, L
    BADEA, BA
    WHITE, SK
    MAIS, DE
    BERGER, E
    SUTO, CM
    GOLDMAN, ME
    HEYMAN, RA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (18) : 2930 - 2941
  • [5] Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disorders
    Breslin, HJ
    Miskowski, TA
    Rafferty, BM
    Coutinho, SV
    Palmer, JM
    Wallace, NH
    Schneider, CR
    Kimball, ES
    Zhang, SP
    Li, J
    Colburn, RW
    Stone, DJ
    Martinez, RP
    He, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) : 5009 - 5020
  • [6] ARTEETHER, A NEW ANTIMALARIAL DRUG - SYNTHESIS AND ANTIMALARIAL PROPERTIES
    BROSSI, A
    VENUGOPALAN, B
    GERPE, LD
    YEH, HJC
    FLIPPENANDERSON, JL
    BUCHS, P
    LUO, XD
    MILHOUS, W
    PETERS, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (03) : 645 - 650
  • [7] Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents
    Chackalamannil, S
    Xia, Y
    Greenlee, WJ
    Clasby, M
    Doller, D
    Tsai, H
    Asberom, T
    Czarniecki, M
    Ahn, HS
    Boykow, G
    Foster, C
    Agans-Fantuzzi, J
    Bryant, M
    Lau, J
    Chintala, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 5884 - 5887
  • [8] Himbacine analogs as muscarinic receptor antagonists-effects of tether and heterocyclic variations
    Chackalamannil, S
    Doller, D
    McQuade, R
    Ruperto, V
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 3967 - 3970
  • [9] Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity
    Chackalamannil, Samuel
    Wang, Yuguang
    Greenlee, William J.
    Hu, Zhiyong
    Xia, Yan
    Ahn, Ho-Sam
    Boykow, George
    Hsieh, Yunsheng
    Palamanda, Jairam
    Agans-Fantuzzi, Jacqueline
    Kurowski, Stan
    Graziano, Michael
    Chintala, Madhu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) : 3061 - 3064
  • [10] An indirubin derivative, E804, exhibits potent angiosuppressive activity
    Chan, Yuk-Kit
    Kwok, Hoi-Hin
    Chan, Lai-Sheung
    Leung, Kelvin Sze-Yin
    Shi, Jue
    Mak, Nai-Ki
    Wong, Ricky Ngok-Shun
    Yue, Patrick Ying-Kit
    [J]. BIOCHEMICAL PHARMACOLOGY, 2012, 83 (05) : 598 - 607
123456